期刊文献+

AEG-1在宫颈癌组织中的表达及临床意义 被引量:3

The expression and clinical significance of AEG - 1 in cervical cancer
下载PDF
导出
摘要 目的探讨AEG-1在宫颈癌中的表达情况及其与临床病理特征的关系。方法应用免疫组织化学sP法检测21例正常宫颈组织、36例宫颈鳞状细胞癌组织、18例宫颈腺癌组织和30例宫颈上皮内瘤样病变(CIN)组织中AEG-1蛋白的表达,并分析其与临床病理特征及肿瘤恶性程度间的关系。结果AEG-1蛋白在宫颈鳞癌和宫颈腺癌组织中的阳性表达率分别为69.4%和72.2%,高于其在CIN组织和正常宫颈组织中40.0%、0.0%的表达率,其差异具有统计学意义(P〈0.05)。AEG-1的阳性表达与宫颈癌临床分期、淋巴结转移、病灶大小、脉管浸润及肌层浸润密切相关,有统计学意义(P〈0.05);与宫颈癌的组织学分级、组织学分型及年龄无关(P〉0.05)。结论AEG-1过表达与宫颈癌的发生、发展密切相关,AEG-1的过表达可作为预测宫颈癌恶性程度和不良预后的重要指标。 Objective To explore the expression of AEG - 1 in cervical cancer and the relationship with clinicopathological characteristics. Methods The expression of AEG - 1 was detected by immunohistochemisty S -P method in 21 cases of normal cervical specimens ,36 cases of squamous carcinoma of the cervix, 18 cases of adenocarcinoma of the uterine cervix and 30 cases of C|N. The correlation between immunohistochemical results and clinicopathological characteristics were analyzed by SPSS software. Results The positive expression ratios of AEG - 1 in squamous carcinoma of the cervix and adenocarcinoma of the uterine cervix were 69.4% and 72.2% respectively, which were significantly higher than those in CIN(40% )and normal cervical tissue(0% ). There was a strong correlation between AEG- 1 expression and clinical staging,lymph nodes metastasis, tumor sizes, vessel invasion and lamina muscularis invasion( P 〈 0.05 ) , whereas it was not associated with histological differentiation, histological classification and age ( P 〉 0.05 ). Conclusion The upregulation of AEG - 1 may play an important role in the development and pothogensis of cervical cancer. The overexpression of AEG - 1 could be a valuable marker to predict the malignant degree and poor prognosis of cervical cancer.
作者 杨兆坤 娄阁
出处 《实用肿瘤学杂志》 CAS 2010年第6期529-532,576,共5页 Practical Oncology Journal
关键词 AEG-1 宫颈癌 宫颈上皮内瘤样病变 生物标志物 AEG - 1 Cervical cancer Cervical intraepithelial neoplasia Biological marker
  • 相关文献

参考文献9

  • 1Kang DC,Su ZZ,Sarkar D,et al.Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1 AEG-1[J].Gene,2005,353(1):8-15.
  • 2Lee SG,Su ZZ,Emdad L,et al.Astrocyte elevated gene-1(AEG-1)is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc[J].Proc Natl Acad Sci USA,2006,103(46):17390-17395.
  • 3Emdad L,Sarkar D,Su ZZ,et al.Astrocyte elevated gene-1:recent insights into a novel gene involved in tumor progression,metastasis and neurodegeneration[J].Pharmacol Ther,2007,114(2):155-170.
  • 4Kikuno N,Shiina H,Urakami S,et al.Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity[J].Oncogene,2007,26(55):7647-7655.
  • 5Brown DM Ruoslahti E.Metadherin,a cell surface protein in breast tumors that mediates lung metastasis[J].Cancer Cell,2004,5(4):365-374.
  • 6Corusic A,Skrgatic L,Mahovlic V,et al.Cervical cancer as a public health issue-what next[J].Coll Antropol,2010,34(1):301-307.
  • 7Sarkar D,Park ES,Emdad L,et al.Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1[J].Cancer Res,2008,68(5):1478-1484.
  • 8Yu C,Chen K,Zheng H,et al.Overexpression of astrocyte elevated gene-1(AEG-1)is associated with esophageal squamous cell carcinoma(ESCC)progression and pathogenesis[J].Carcinogenesis,2009,30(5):894-901.
  • 9张薛榜,李文峰,吴式绣,邹长林,邹三鹏,李明众.VEGF-C、CD_(44)V_6表达与宫颈癌淋巴结转移的相关性研究[J].实用肿瘤学杂志,2005,19(3):170-172. 被引量:2

二级参考文献11

  • 1Joukov V, Pajusola K.Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases [J]. EMBOJ, 1996;15(2):290~298
  • 2Amioka T, Kitadai Y, Tanaka S, et al. Vascular endothelial growth factor C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa [J]. Eur J Cancer, 2002;38(10):1413~1419
  • 3Straume O, Jackson DG, Akslen LA. Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanom [J]. Clin Cancer Res, 2003;9(1):250~256
  • 4Saaristo A, Veikkola T, Tammela T, et al. Lymphangiogenic gene therapy with minimal blood vascular side effects [J]. J Exp Med, 2002;196(6):719~730
  • 5Makinen T, Veikkola T, et al. Isolated lymphaatic endothelial cells tranduce growth, Surival and migratory signals via the VEGF-C/D receptor VEGFR-3 [J]. Em Bo J, 2001;20(17):4762~4773
  • 6Matsumura K, Hirashima M. Modulation of VEGFR-2 mediated endothelial-cell activity by VEGF-C/VEGFR-3 [J]. Blood, 2002;10(202):587~591
  • 7Shin HY, Smith ML, Toy KJ, et al. VEGF-C medlates cyclic pressure induced entholial cell proliferation [J]. Physiol Genomics, 2002;82(10):1169~1173
  • 8Castenholz A. Functional microanatomy of initial lymphatic with specional cosideration of the extracellar matrix [J]. Lymphology, 1998;31(3):101~118
  • 9Padera TP, Kadambi A, di Tomaso E, et al. Lymphatic metastasis in the absence of functional intratumor lymphatics [J]. Science, 2002;296(5574):1883~1886
  • 10Ristimaki A, Narko K, Enholm B, et al. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C [J]. J Biochem, 1998;272(14):8413~8418

共引文献1

同被引文献66

  • 1Hongtao S, Cong L, Rui L, et al. Prognostic significance of AEG - 1 expression in colorectal carcinoma[ J ]. Int J Colo- rectal Dis,2010,25(10) :1201 - 1209.
  • 2Hongtao S, Cong L, Renbo L, et al. Expression of AEG - 1 : A novel marker of the pathogenesis, progression and poor prognosis for endometrial cancer [ J ]. Int J Gynecol Cane- er,2010,20(7) : 1188 - 1196.
  • 3Cong L, Junjun L, Renbo L, et al. AEG - 1 over - expres- sion:a novel indicator for peritoneal dissemination and lymph node metastasis in epithelial ovarian cancers [ J ]. Int J Gynecol Cancer,2011,22 (9) :5615 - 5620.
  • 4Benedet JL, Bender H, Jones H,et al. FIGO staging classi- fications and clinical practice guidelines in the manage- ment of gynecologic cancers. FIGO Committee on Gyneco- logic Oncology[ J ]. Int J Gynaecol Obstet, 2000,70 (2) : 209 - 262.
  • 5Scully R. Histological typing of ovarian tumors (WHO. World Health Organization. International Histological Classification of Tumours ) [ M ]. Springer, Berlin; 1999 : 20.
  • 6Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2010 [ J]. CA Cancer J Clin,2010 ,60 :277 - 300.
  • 7Ozols RF, Bookman MA, Connolly DC, et al. Focus on epi- thelial ovarian cancer[ J]. Cancer Cell ,2005,5 : 19 - 24.
  • 8Holschneider CH, BerekJS. Ovarian cancer: epidemiology, biology, and prognostic factors [ J ]. Semin Surg Oncol, 2000,19( 1 ) :3 - 10.
  • 9Su ZZ, Kang DC, Chen Y, et al. Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV - 1 or exposure to HIV - 1 envelope glycoprotein by rapid subtraction hybridization, RaSH [ J ]. Oncogene,2002,21 (22) : 3592 - 3602.
  • 10Thirkettle H J, Girling J, Warren AY, et al. LYRIC/AEG - 1 is targeted to different subcellular compartments by ubiquitinylation and intrinsic nuclear localization signals [ J ]. Clin Cancer Res ,2009,15 (9) :3003 - 3013.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部